logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
H

Haizhu Chen

sun yat-sen memorial hospital
H指数:14
被引数:527

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Fulvestrant versus capecitabine as maintenance therapy in hormone receptor-positive, HER2-negative metastatic breast cancer after first-line chemotherapy (FAMILY): a multicenter, open-label, randomized, phase 3 trial

氟维司群与卡培他滨作为激素受体阳性HER2-negative转移性乳腺癌一线化疗后的维持治疗 (FAMILY): 一项多中心、开放标签、随机、3期临床试验

Signal Transduction and Targeted Therapy
IF52.7
2026-05-220
OAAI
Wenjing Wu; Yaping Yang; Haizhu Chen; Yongkui Lu; Yinduo Zeng; Jianli Zhao; Caiwen Du; Ying Lin; Peijian Peng; Mei Huang; Ying Zhang; Quchang Ouyang; Linxiaoxiao Ding; Ziliang Cheng; Yuanyu Wen; Zhiyong Wu; Jinhui Ye; Li Ling; Kun Wang; Ying Lu; Guorong Zou; Jincai Zhong; Hong Wang; Daren Lin; De Zeng; Chengcai Yao; Qianjun Chen; Liqun Zou; Shusen Wang; Yunfang Yu; Zhongyu Yuan; Ying Wang; Herui Yao
Single-cell and spatial transcriptomics reveal a high glycolysis B cell and tumor-associated macrophages cluster correlated with poor prognosis and exhausted immune microenvironment in diffuse large B-cell lymphoma

单细胞和空间转录组学揭示高糖酵解b细胞和肿瘤相关巨噬细胞簇与弥漫性大b细胞淋巴瘤的不良预后和耗尽的免疫微环境相关

BIOMARKER RESEARCH
IF11.5
2024-06-053
OAAI
Dai, Liyuan; Fan, Guangyu; Xie, Tongji; Li, Lin; Tang, Le; Chen, Haizhu; Shi, Yuankai; Han, Xiaohong
Assessing real-world safety concerns of Sacituzumab govitecan: a disproportionality analysis using spontaneous reports in the FDA adverse event reporting system

评估Sacituzumab govitecan的真实世界安全性问题: 使用FDA不良事件报告系统中的自发报告进行不成比例分析

FRONTIERS IN ONCOLOGY
IF3.3
2023-10-068
OAAI
Gui, Xiujuan; Zhao, Jianli; Ding, Linxiaoxiao; Chai, Jie; Lai, Hongna; Cai, Yangyang; Luo, Simin; Zeng, Yinduo; Wu, Wenjing; Chen, Haizhu; Yao, Herui; Wang, Ying

研究方向

暂未获取到该数据
Y
Yu Zhou
H 指数:20论文数:91被引数:1,207
Y
Yunxia Tao
H 指数:30论文数:70被引数:2,793
H
Herui Yao
H 指数:54论文数:382被引数:1.4万
Y
Yuankai Shi
H 指数:49论文数:542被引数:1.3万
韩晓红 封面图
韩晓红
H 指数:32论文数:369被引数:4,169
Y
Yuankai Shi
H 指数:20论文数:250被引数:1,736
X
Xiaohui He
H 指数:28论文数:263被引数:4,463
Y
Yan Qin
H 指数:25论文数:228被引数:2,675
S
Shengyu Zhou
H 指数:25论文数:205被引数:2,756
J
Jianliang Yang
H 指数:21论文数:158被引数:1,551